Abstract

Abstract Advances in our understanding of the biological basis and molecular characteristics of ependymal tumors since the latest iteration of the World Health Organization (WHO) classification of CNS tumors (2016) have prompted the cIMPACT‐NOW group to recommend a new classification. Separation of ependymal tumors by anatomic site is an important principle of the new classification and was prompted by methylome profiling data to indicate that molecular groups of ependymal tumors in the posterior fossa and supratentorial and spinal compartments are distinct. Common recurrent genetic or epigenetic alterations found in tumors belonging to the main molecular groups have been used to define tumor types at intracranial sites; C11orf95 and YAP1 fusion genes for supratentorial tumors and two types of posterior fossa ependymoma defined by methylation group, PFA and PFB. A recently described type of aggressive spinal ependymoma with MYCN amplification has also been included. Myxopapillary ependymoma and subependymoma have been retained as histopathologically defined tumor types, but the classification has dropped the distinction between classic and anaplastic ependymoma. While the cIMPACT‐NOW group considered that data to inform assignment of grade to molecularly defined ependymomas are insufficiently mature, it recommends assigning WHO grade 2 to myxopapillary ependymoma and allows grade 2 or grade 3 to be assigned to ependymomas not defined by molecular status.

Keywords

EpendymomaPathologyBrain tumorBiologyEpendymal CellPosterior fossaMedicineImmunohistochemistryAnatomy

Affiliated Institutions

Related Publications

<scp>I</scp>nternational <scp>S</scp>ociety of <scp>N</scp>europathology‐<scp>H</scp>aarlem <scp>C</scp>onsensus <scp>G</scp>uidelines for <scp>N</scp>ervous <scp>S</scp>ystem <scp>T</scp>umor <scp>C</scp>lassification and <scp>G</scp>rading

Abstract Major discoveries in the biology of nervous system tumors have raised the question of how non‐histological data such as molecular information can be incorporated into t...

2014 Brain Pathology 559 citations

Publication Info

Year
2020
Type
review
Volume
30
Issue
5
Pages
863-866
Citations
278
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

278
OpenAlex

Cite This

David W. Ellison, Kenneth Aldape, David Capper et al. (2020). cIMPACT‐NOW update 7: advancing the molecular classification of ependymal tumors. Brain Pathology , 30 (5) , 863-866. https://doi.org/10.1111/bpa.12866

Identifiers

DOI
10.1111/bpa.12866